SMTL ID : 6zg9.1

Structure of M1-StaR-T4L in complex with GSK1034702 at 2.5A

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x QK2: 7-fluoranyl-5-methyl-3-[1-(oxan-4-yl)piperidin-4-yl]-1~{H}-benzimidazol-2-one(Non-covalent)

QK2.1: 14 residues within 4Å: Chain A: S.59, L.62, Y.63, Y.66, W.72, L.83, D.86, S.90, C.159, Y.160, W.385, Y.388, Y.411, Y.415 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.62, A:Y.63, A:L.83, A:Y.411, A:Y.411 Hydrogen bonds: A:C.159 Salt bridges: A:D.86 pi-Cation interactions: A:Y.411

1 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)

EPE.2: 9 residues within 4Å: Chain A: Y.160, L.164, S.165, P.167, T.170, S.395, E.404, W.407, Y.411 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:T.170, A:S.395, A:S.395 pi-Cation interactions: A:W.407

6 x OLA: OLEIC ACID(Non-covalent)

OLA.3: 10 residues within 4Å: Chain A: I.31, Q.38, Y.43, F.46, I.54, L.85, L.124, I.127, W.131 Ligands: OLA.4 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:Y.43, A:Y.43, A:F.46, A:I.54, A:L.85, A:L.124, A:I.127, A:W.131, A:W.131, A:W.131 OLA.4: 10 residues within 4Å: Chain A: A.84, L.85, V.88, L.124, I.127, G.128, W.131, F.135 Ligands: OLA.3, OLA.7 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:A.84, A:L.85, A:V.88, A:W.131, A:W.131, A:F.135 Hydrogen bonds: A:G.128 OLA.5: 8 residues within 4Å: Chain A: E.5, I.9, T.405, E.408, L.409, W.412, L.413 Ligands: OLA.8 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:I.9, A:I.9, A:T.405, A:W.412, A:W.412, A:W.412, A:L.413 Hydrogen bonds: A:E.5 OLA.6: 8 residues within 4Å: Chain A: L.74, G.75, A.76, L.77, A.78, L.81, A.156 Ligands: OLA.7 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:A.76, A:L.77, A:A.78, A:L.81 Hydrogen bonds: A:A.76 Water bridges: A:G.157 OLA.7: 14 residues within 4Å: Chain A: L.62, V.65, Y.66, M.69, H.71, W.72, A.73, L.74, A.78, L.81, A.82, L.85 Ligands: OLA.4, OLA.6 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.62, A:V.65, A:L.74, A:A.78, A:L.81, A:L.85 Hydrogen bonds: A:A.73, A:L.74 OLA.8: 4 residues within 4Å: Chain A: I.9, T.405, L.409 Ligands: OLA.5 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:I.9, A:T.405, A:L.409

1 x PO4: PHOSPHATE ION(Non-functional Binders)

PO4.9: 5 residues within 4Å: Chain A: R.110, L.112, S.113, D.271, R.275 8 PLIP interactions: 8 interactions with chain A Hydrogen bonds: A:L.112, A:S.113, A:S.113, A:S.113, A:D.271, A:D.271, A:D.271 Salt bridges: A:R.110

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Brown, A.J.H. et al., From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's disease. Cell (2021)

Release Date

2021-10-06

Peptides

Muscarinic acetylcholine receptor M1,Endolysin,Muscarinic acetylcholine receptor M1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Muscarinic acetylcholine receptor M1,Endolysin,Muscarinic acetylcholine receptor M1

Related Entries With Identical Sequence